News Image

NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update

Provided By GlobeNewswire

Last update: Feb 26, 2025

-- EMA submission expected in 2H25 by partner Menarini --

-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025 --

Read more at globenewswire.com

NEWAMSTERDAM PHARMA CO NV

NASDAQ:NAMS (6/13/2025, 8:25:22 PM)

After market: 20.21 0 (0%)

20.21

-0.82 (-3.9%)


NEWAMSTERDAM PHARMA CO NV-27

NASDAQ:NAMSW (6/13/2025, 8:25:22 PM)

9.41

-0.66 (-6.55%)



Find more stocks in the Stock Screener

NAMS Latest News and Analysis

ChartMill News Image7 days ago - ChartmillGet insights into the top gainers and losers of Monday's pre-market session.

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Mentions: BPT NCL PLCE SATS ...

Follow ChartMill for more